中国药物警戒 ›› 2010, Vol. 7 ›› Issue (11): 690-693.

• 药品不良反应监测 • 上一篇    下一篇

631例血塞通注射液不良反应/事件报告分析

李文武1, 张惠霞1,杨莎莎2, 刘超1   

  1. 1.河南省食品药品评价中心,河南郑州450004；
    2.河南大学药学院,河南开封475004
  • 收稿日期:2010-04-23 修回日期:2016-03-09 出版日期:2010-11-08 发布日期:2016-03-09
  • 作者简介:李文武,男,硕士,药品不良反应监测。

Analysis of 631 Reports of ADR/ADE Caused by Xuesaitong Injection

LI Wen-wu1 ,ZHANG Hui-xia1, YANG Sha-sha2 ,LIU Chao1   

  1. Henan Center for Drug Reevaluation, Henan Zhenzhou 450004; Pharmaceutical College of Henan University, Henan Kaifeng, 475004
  • Received:2010-04-23 Revised:2016-03-09 Online:2010-11-08 Published:2016-03-09

PDF (PC)

630

摘要： 目的通过探讨血塞通注射液不良反应发生的一般规律和特点,为临床合理用药提供参考。方法采用回顾性研究方法,对2004～2009年我中心收集的631 例血塞通注射液药品不良反应/ 事件报告进行统计分析。结果60 岁以上的患者259 例,占41.05%；药品不良反应发生时间在30 分钟以内的患者233 例,占36.93%；超剂量用药186例,占29.48%；联合用药125 例,占19.81%；不良反应主要表现为皮肤损害。结论应加强对血塞通注射液的监测,提高临床合理用药水平,减少不良反应的发生。

关键词: 血塞通注射液, 药品不良反应/事件, 分析

Abstract: Objective To study the general pattern and characteristics of adverse drug reactions induced by Xuesaitong injection to provide references for clinical rational use of drug. Methods 631 ADR/ADE reports of Xuesaitong injection collected by Henan center for ADR monitoring from 2004 to 2009 were analyzed using retrospective study method. Results 259 cases of patients over the age of 60 accounted for 41.05% ;233 cases of patients with ADR/ADE occurred within 30 minutes accounted for 36.93%; 186 cases of drug overdose accounted for 29.48%;125 cases of combination therapy accounted for 19.81%; ADR/ADE mainly were skin allergies. Conclusion ADR monitoring should be strengthened to improve the rational use of drug and reduce the occurrence of ADR/ADE.

Key words: Xuesaitong injection, adverse drug reaction/event(ADR/ADE), analysis

中图分类号: